Product Categories
| Country: | United States |
|---|---|
| Tel: | 781-+1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | info@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36 Washington Street, Wellesley Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| 4-Acetamidophenyl acetate | C10H11NO3 | 2623-33-8 | Details |
| 4-Acetylsimvastatin | C27H40O6 | 145576-25-6 | Details |
| 4-Bromo A23187；4-?Bromo A23187 | C29H36BrN3O6 | 76455-48-6 | Details |
| 4-Desmethoxy Omeprazole | C16H17N3O2S | 110374-16-8 | Details |
| 4-Desmethyl Istradefylline | C19H22N4O4 | 160434-48-0 | Details |
| 4-Diethylaminobenzaldehyde | C11H15NO | 120-21-8 | Details |
| 4'-Ethynyl-2'-deoxyadenosine | C12H13N5O3 | 306305-07-7 | Details |
| p-Ethynylphenylalanine；4-Ethynyl-L-phenylalanine | C11H11NO2 | 278605-15-5 | Details |
| 4-Hydroxyacetophenone oxime | C8H9NO2 | 34523-34-7 | Details |
| 4-Hydroxyatomoxetine D3 | C17H21NO2 | 1217686-14-0 | Details |
| 4-Hydroxyatomoxetine | C17H21NO2 | 435293-66-6 | Details |
| 4-Hydroxyderricin | C21H22O4 | 55912-03-3 | Details |
| 4-Hydroxymephenytoin | C12H14N2O3 | 61837-65-8 | Details |
| 4-Hydroxynonenal；4-HNE | C9H16O2 | 75899-68-2 | Details |
| 4-Hydroxypropranolol-d7 hydrochloride；4-Hydroxypropranolol D7 hydrochloride;(±)-4-hydroxy Propranolol D7 hydrochloride | C16H15ClD7NO3 | 1219804-03-1 | Details |
| 4-Hydroxypropranolol hydrochloride；(±)-4-hydroxy Propranolol hydrochloride | C16H22ClNO3 | 14133-90-5 | Details |
| 5-Lipoxygenase-In-1 | C23H28N4O2S | 125235-15-6 | Details |
| 4-Methylamino antipyrine | C12H15N3O | 519-98-2 | Details |
| 4-Methylamino antipyrine hydrochloride | C12H16ClN3O | 856307-27-2 | Details |
| 4-O-Methyl honokiol | C19H20O2 | 68592-15-4 | Details |
| MAO-B-IN-1 | C16H14F3N3O2S | 1124198-17-9 | Details |
| 4'-Raloxifene-β-D-glucopyranoside | C34H37NO9S | 334758-19-9 | Details |
| CCR3 antagonist 1 | C19H21Cl2N3O4S2 | 879399-82-3 | Details |
| Regorafénib N-oxyde (M2) | C21H15ClF4N4O4 | 835621-11-9 | Details |
| 42-(2-Tetrazolyl)rapamycin | C52H79N5O12 | 221877-56-1 | Details |
| 48740 RP；RP-55778 | C12H11N3OS | 93363-11-2 | Details |
| D-α-Tocopherol acetate；Vitamin E Acetate;Tocopherol acetate | C31H52O3 | 58-95-7 | Details |
| 11β-HSD1-IN-1 | C18H14ClF4N3O | 1203956-47-1 | Details |
| Antiasthmatic Compound 1 | C14H9NO5 | 63768-49-0 | Details |
| 5-HT3 antagonist 3 | C20H21N3O | 120635-47-4 | Details |
| 4'-Methylchrysoeriol | C17H14O6 | 4712-12-3 | Details |
| 5,6-Dihydroxyindole | C8H7NO2 | 3131-52-0 | Details |
| 5-A-RU；5-Amino-6-(D-ribitylamino)uracil | C9H16N4O6 | 17014-74-3 | Details |
| 5-A-RU hydrochloride；5-Amino-6-(D-ribitylamino)uracil hydrochloride | C9H17ClN4O6 | 134452-11-2 | Details |
| Lipid peroxidation inhibitor 1 | C24H32N2O | 142873-41-4 | Details |
| 5-Dehydroepisterol | C28H44O | 23582-83-4 | Details |
| 5-HT1A modulator 1 | C21H25N3O2S | 142477-34-7 | Details |
| 5-HT4 antagonist 1 | C23H36N4O5S | 261766-73-8 | Details |
| Fluorothyl；Flurothyl;Bis(2,2,2-trifluoroethyl) ether;Fluoroethyl | C4H4F6O | 333-36-8 | Details |
| 5-HT7 agonist 1 | C19H20ClN3 | 334974-31-1 | Details |
| 5-Hydroxypyrazine-2-Carboxylic Acid | C5H4N2O3 | 34604-60-9 | Details |
| 5-Iodo-indirubin-3'-monoxime | C16H10IN3O2 | 331467-03-9 | Details |
| MCHR1 antagonist 1 | C28H33F2N5O5 | 391610-37-0 | Details |
| 5-R-Rivaroxaban | C19H18ClN3O5S | 865479-71-6 | Details |
| (5E,9E,13E)-Teprenone；(5E,9E,13E)-Geranylgeranylacetone | C23H38O | 3796-63-2 | Details |
| TRPV antagonist 1 | C26H21F3N2O4S | 1192871-27-4 | Details |
| 24-Hydroxycholesterol | C27H46O2 | 30271-38-6 | Details |
| 24-Norursodeoxycholic acid；nor-UDCA | C23H38O4 | 99697-24-2 | Details |
| 24R-Calcipotriol；PRI 2202 | C27H40O3 | 112827-99-3 | Details |
| 2614W94 | C15H11F3O4S | 205187-35-5 | Details |
| Estrone；Fluoroethyl;Oestrone;Aquacrine | C18H22O2 | 53-16-7 | Details |
| 264W94 | C23H31NO4S | 178961-24-5 | Details |
| Anti-inflammatory agent 1 | C17H16O3S | 1096621-42-9 | Details |
| PSN-GK1 | C20H23FN2O4S2 | 745051-61-0 | Details |
| (2R,3R)-E1R | C13H16N2O2 | 1400888-63-2 | Details |
| E1R | C13H16N2O2 | 1301211-78-8 | Details |
| (2R,3S)-E1R | C13H16N2O2 | 1424832-60-9 | Details |
| (2R,4R)-APDC | C6H10N2O4 | 169209-63-6 | Details |
| (2S,3R)-Voruciclib | C22H19ClF3NO5 | 1253731-24-6 | Details |
| (2S,3S)-E1R | C13H16N2O2 | 1424832-57-4 | Details |
| PGS-IN-1；KME-4 | C19H26O3 | 102271-49-8 | Details |
| 2'-Deoxypseudoisocytidine | C9H13N3O4 | 65358-18-1 | Details |
| Verapamil hydrochloride；Calcan hydrochloride;Manidon;Verapamil HCl;(±)-Verapamil hydrochlorid | C27H39ClN2O4 | 152-11-4 | Details |
| QF0301B | C23H28N2O2 | 149247-12-1 | Details |
| Calcium channel-modulator-1 | C26H24Cl2N2O7S | 136941-70-3 | Details |
| 3,3'-Diiodo-L-thyronine；3,3'-T2 | C15H13I2NO4 | 4604-41-5 | Details |
| 3,4-Dihydroxybenzylamine hydrobromide；NSC 263475 hydrobromide | C7H10BrNO2 | 16290-26-9 | Details |
| 3α-Hydroxymogrol | C30H52O4 | 1343402-73-2 | Details |
| 3-arylisoquinolinamine derivative | C18H19N3O | 1029008-71-6 | Details |
| 3-Bromo-7-nitroindazole | C7H4BrN3O2 | 74209-34-0 | Details |
| 3-Bromocytisine；3-Br-cytisine | C11H13BrN2O | 207390-14-5 | Details |
| 3-Carene | C10H16 | 13466-78-9 | Details |
| Itraconazole；R51211 | C35H38Cl2N8O4 | 84625-61-6 | Details |
| 3-CPs；3-Carbethoxypsoralen | C14H10O5 | 20073-24-9 | Details |
| 3-Deazaadenosine hydrochloride | C11H15ClN4O4 | 86583-19-9 | Details |
| 3-Deazaadenosine | C11H14N4O4 | 6736-58-9 | Details |
| 3-Hydroxy-4-methoxyacetophenone；Acetoisovanillone | C9H10O3 | 6100-74-9 | Details |
| 3-Hydroxy agomelatine D3 | C15H17NO3 | 1079774-23-4 | Details |
| 3-Hydroxy agomelatine | C15H17NO3 | 166526-99-4 | Details |
| 3'-?O-?Acetylhamaudol | C17H18O6 | 30358-88-4 | Details |
| 3-O-Methyltolcapone；Ro 40-7591 | C15H13NO5 | 134612-80-9 | Details |
| Acebutolol hydrochloride；Acebutolol HCl | C18H29ClN2O4 | 34381-68-5 | Details |
| 3-Oxo Atorvastatin | C33H33FN2O5 | 887196-30-7 | Details |
| 3-Nitrocoumarin | C9H5NO4 | 28448-04-6 | Details |
| 3-O-Acetylbufotalin | C28H38O7 | 4029-69-0 | Details |
| Substance P Receptor Antagonist 1 | C24H29F3N2O2 | 225526-17-0 | Details |
| Anti-neurodegeneration agent 1 | C14H20ClN3O3 | 289893-23-8 | Details |
| Antiulcer Agent 1 | C19H23N3O4 | 76001-09-7 | Details |
| (3R,4R)-A2-32-01 | C19H27NO2 | 1359752-95-6 | Details |
| VEGFR-2-IN-9；KDR-in-4 | C23H25N3O3 | 408502-06-7 | Details |
| (3R,5R)-Rosuvastatin | C22H28FN3O6S | 1094100-06-7 | Details |
| (3R,5S)-Atorvastatin sodium | C33H34FN2O5.Na | 131275-93-9 | Details |
| (3S,5R)-Fluvastatin D6 sodium；(3S,5R)-XU 62-320 D6 | C24H27FNNaO4 | 2249799-35-5 | Details |
| (3S,5R)-Fluvastatin sodium；(3S,5R)-XU 62-320 | C24H25FNNaO4 | 94061-81-1 | Details |
| Amikacin；Amikacine;Amikacina;Amikacinum | C22H43N5O13 | 37517-28-5 | Details |
| (3S,5R)-Pitavastatin calcium | C25H26CaFNO4 | 254452-88-5 | Details |
| (3S,5R)-Rosuvastatin | C22H28FN3O6S | 1242184-42-4 | Details |
| (3S,5S)-Pitavastatin calcium | C25H26CaFNO4 | 254452-92-1 | Details |
| 3'-Azido-3'-deoxy-5-methylcytidine | C10H14N6O4 | 1282040-14-5 | Details |
| 4,7,10,13,16-Docosapentaenoic acid | C22H34O2 | 2313-14-6 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 | ||||